MedTrace Logo

DORAYA-HF OUS Assessment of the Doraya Catheter for the Treatment of ADHF Patients With Insufficient Response to Diuretics

NCT05876078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-03-09

No results posted yet for this study

Summary

The study objective is to evaluate the feasibility of the Doraya Catheter and measure clinical performance and safety endpoints, in ADHF patients deemed to have insufficient diuretic response.

Conditions

  • Acute Decompensated Heart Failure

Interventions

DEVICE

Doraya catheter

Temporary deployment of the Doraya catheter in ADHF patients

Sponsors & Collaborators

  • Revamp Medical Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2026-02-28
Completion
2026-02-28
FDA Device
Yes

Countries

  • Germany
  • Italy
  • Poland
  • Slovakia
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05876078 on ClinicalTrials.gov